Canvaxin: Phase II data; 2 Phase III trials on hold

In a U.S. Phase II trial in 2,602 patients that underwent lympadenectomy to treat Stage III melanoma, a retrospective matched-pair analysis showed the median overall survival between Canvaxin-treated ...